Ashley V. Menk

7.1k total citations · 6 hit papers
34 papers, 4.6k citations indexed

About

Ashley V. Menk is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ashley V. Menk has authored 34 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Ashley V. Menk's work include Immune Cell Function and Interaction (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and CAR-T cell therapy research (9 papers). Ashley V. Menk is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and CAR-T cell therapy research (9 papers). Ashley V. Menk collaborates with scholars based in United States, China and Australia. Ashley V. Menk's co-authors include Greg M. Delgoffe, Nicole E. Scharping, Ryan D. Whetstone, Amanda C. Poholek, Kristin DePeaux, Natalie Rittenhouse, Xue Zeng, Stacy G. Wendell, Paolo Vignali and Rebecca S. Moreci and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Ashley V. Menk

33 papers receiving 4.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic support of tumour-infiltrating regulatory T cells by lactic acid

2021 817 citations McLane J. Watson, Paolo Vignali et al. Nature profile →
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

2016 562 citations Nicole E. Scharping, Ashley V. Menk et al. Immunity profile →
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion

2021 548 citations Nicole E. Scharping, Dayana B. Rivadeneira et al. Nature Immunology profile →
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia

2016 399 citations Nicole E. Scharping, Ashley V. Menk et al. Cancer Immunology Research profile →
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions

2018 343 citations Ashley V. Menk, Nicole E. Scharping et al. Cell Reports profile →
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

2022 163 citations Paolo Vignali, Kristin DePeaux et al. Nature Immunology profile →

Peers

Countries citing papers authored by Ashley V. Menk

Since Specialization

Citations

This map shows the geographic impact of Ashley V. Menk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley V. Menk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley V. Menk more than expected).

Fields of papers citing papers by Ashley V. Menk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley V. Menk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley V. Menk. The network helps show where Ashley V. Menk may publish in the future.

Co-authorship network of co-authors of Ashley V. Menk

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley V. Menk. A scholar is included among the top collaborators of Ashley V. Menk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley V. Menk. Ashley V. Menk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Excess Dietary Sugar Alters Colonocyte Metabolism and Impairs the Proliferative Response to Damage 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·Ansen B.P. Burr, Junyi Ji, (unknown), (unknown), Onur Eskiocak, Brian Yueh, (unknown), Ashley V. Menk, Natalie Rittenhouse, (unknown), Pailin Chiaranunt, Xiaoyi Zhang, (unknown), Abigail E. Overacre-Delgoffe, Vaughn S. Cooper, Amanda C. Poholek, Greg M. Delgoffe, Kevin P. Mollen, Semir Beyaz, Timothy W. Hand	15
2	Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors 2023 ·Journal for ImmunoTherapy of Cancer ·Konstantinos Lontos, Yiyang Wang, (unknown), Andrew Frisch, McLane J. Watson, Alok Kumar, Ashley V. Menk, Yupeng Wang, (unknown), Jason Lohmueller, Esteban Carrizosa, Benjamin Boyerinas, Greg M. Delgoffe	59
3	Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity breakdown → 2022 ·Nature Immunology ·Paolo Vignali, Kristin DePeaux, McLane J. Watson, (unknown), B. Rhodes Ford, Konstantinos Lontos, (unknown), Nicole E. Scharping, Ashley V. Menk, Simon C. Robson, Amanda C. Poholek, Dayana B. Rivadeneira, Greg M. Delgoffe	163
4	Metabolic support of tumour-infiltrating regulatory T cells by lactic acid breakdown → 2021 ·Nature ·McLane J. Watson, Paolo Vignali, Steven J. Mullett, Abigail E. Overacre-Delgoffe, Ronal M. Peralta, Stephanie Grebinoski, Ashley V. Menk, Natalie Rittenhouse, Kristin DePeaux, Ryan D. Whetstone, Dario A.A. Vignali, Timothy W. Hand, Amanda C. Poholek, Brett M. Morrison, Jeffrey D. Rothstein, Stacy G. Wendell, Greg M. Delgoffe	817
5	Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion breakdown → 2021 ·Nature Immunology ·Nicole E. Scharping, Dayana B. Rivadeneira, Ashley V. Menk, Paolo Vignali, B. Rhodes Ford, Natalie Rittenhouse, Ronal M. Peralta, Yiyang Wang, Yupeng Wang, Kristin DePeaux, Amanda C. Poholek, Greg M. Delgoffe	548
6	Analyzing Melanoma Cell Oxygen Consumption and Extracellular Acidification Rates Using Seahorse Technology 2021 ·Methods in molecular biology ·Ashley V. Menk, Greg M. Delgoffe	1
7	Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells 2019 ·Cancer Immunology Research ·P.M.L. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe, Lisa H. Butterfield	52
8	IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell 2019 ·Cancer Immunology Research ·Lulu Shao, Weizhou Hou, Nicole E. Scharping, Frank P. Vendetti, Rashmi Srivastava, Chandra Nath Roy, Ashley V. Menk, (unknown), Joë-Marc Chauvin, (unknown), Stephen H. Thorne, Veit Hornung, Hassane M. Zarour, Christopher J. Bakkenist, Greg M. Delgoffe, Saumendra N. Sarkar	52
9	The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8+ Memory T Cell Maintenance and Secondary Response to Infection 2019 ·The Journal of Immunology ·(unknown), (unknown), Lisa Beppu, Ashley V. Menk, Callen T. Wallace, William F. Hawse, Heather M. Buechel, Bernice H. Wong, Juat Chin Foo, Amaury Cazenave‐Gassiot, Markus R. Wenk, Greg M. Delgoffe, Simon C. Watkins, David L. Silver, Louise M. D’Cruz	27
10	Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance 2019 ·Immunity ·Dayana B. Rivadeneira, Kristin DePeaux, Yiyang Wang, Aditi Kulkarni, Tracy Tabib, Ashley V. Menk, Padmavathi Sampath, Robert Lafyatis, Robert L. Ferris, Saumendra N. Sarkar, Stephen H. Thorne, Greg M. Delgoffe	110
11	Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma 2019 ·JCI Insight ·Yana G. Najjar, Ashley V. Menk, Cindy Sander, (unknown), Arivarasan Karunamurthy, Roma Bhatia, Shuyan Zhai, John M. Kirkwood, Greg M. Delgoffe	171
12	Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ 2019 ·Immunity ·Chang Liu, Maria Chikina, Rahul Deshpande, Ashley V. Menk, Ting Wang, Tracy Tabib, Erin A. Brunazzi, Kate M. Vignali, Ming Sun, Donna B. Stolz, Robert Lafyatis, Wei Chen, Greg M. Delgoffe, Creg J. Workman, Stacy G. Wendell, Dario A.A. Vignali	266
13	IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival 2019 ·Nature Immunology ·Saikat Majumder, Nilesh Amatya, Shankar Revu, Chetan V. Jawale, (unknown), Natalie Rittenhouse, Ashley V. Menk, (unknown), Fang Du, Itay Raphael, Amrita Bhattacharjee, Ulrich Siebenlist, Timothy W. Hand, Greg M. Delgoffe, Amanda C. Poholek, Sarah L. Gaffen, Partha S. Biswas, Mandy J. McGeachy	76
14	Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted 2018 ·Journal of Clinical Investigation ·Jeremy S. Tilstra, Lyndsay Avery, Ashley V. Menk, Rachael A. Gordon, Shuchi Smita, Larry Kane, Maria Chikina, Greg M. Delgoffe, Mark J. Shlomchik	104
15	IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation 2018 ·Cell Reports ·Shankar Revu, Jing Wu, Matthew Henkel, Natalie Rittenhouse, Ashley V. Menk, Greg M. Delgoffe, Amanda C. Poholek, Mandy J. McGeachy	157
16	Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions breakdown → 2018 ·Cell Reports ·Ashley V. Menk, Nicole E. Scharping, Rebecca S. Moreci, Xue Zeng, Cliff Guy, Sonia R. Salvatore, Heekyong Bae, Jianxin Xie, Howard A. Young, Stacy G. Wendell, Greg M. Delgoffe	343
17	Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia breakdown → 2016 ·Cancer Immunology Research ·Nicole E. Scharping, Ashley V. Menk, Ryan D. Whetstone, Xue Zeng, Greg M. Delgoffe	399
18	Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions 2016 ·The Journal of Immunology ·Binh Phong, Lyndsay Avery, Ashley V. Menk, Greg M. Delgoffe, Larry Kane	37
19	The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction breakdown → 2016 ·Immunity ·Nicole E. Scharping, Ashley V. Menk, Rebecca S. Moreci, Ryan D. Whetstone, Rebekah Dadey, Simon C. Watkins, Robert L. Ferris, Greg M. Delgoffe	562
20	Cutting Edge: Differential Regulation of PTEN by TCR, Akt, and FoxO1 Controls CD4+ T Cell Fate Decisions 2015 ·The Journal of Immunology ·William F. Hawse, Robert P. Sheehan, Nataša Miškov-Živanov, Ashley V. Menk, Larry Kane, James R. Faeder, Penelope A. Morel	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact